Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Ken Tajima
Role of FBXW7 in the Quiescence of Gefitinib-Resistant Lung Cancer Stem Cells in EGFR-mutant Non-Small Cell Lung Cancer
Bosnian Journal of Basic Medical Sciences
Medicine
Related publications
Noninvasive Detection of EGFR T790M in Gefitinib or Erlotinib Resistant Non-Small Cell Lung Cancer
Clinical Cancer Research
Cancer Research
Oncology
Author Correction: Targeting Hsp90 With FS-108 Circumvents Gefitinib Resistance in EGFR Mutant Non-Small Cell Lung Cancer Cells
Acta Pharmacologica Sinica
Medicine
Pharmacology
A Case of Small Cell Lung Cancer Transformation From EGFR-Mutant Lung Adenocarcinoma With Primary Resistance to Gefitinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
ERK Inhibition Represses Gefitinib Resistance in Non-Small Cell Lung Cancer Cells
Oncotarget
Oncology
Inhibition of SREBP Increases Gefitinib Sensitivity in Non-Small Cell Lung Cancer Cells
Oncotarget
Oncology
Gefitinib Induces Premature Senescence in Non-Small Cell Lung Cancer Cells With or Without EGFR Gene Mutation
Oncology Reports
Medicine
Cancer Research
Oncology
Cancer Stem Cells in Lung Cancer: Distinct Differences Between Small Cell and Non-Small Cell Lung Carcinomas
OA14 Phase 2 Study: Tepotinib + Gefitinib in MET+/Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Gefitinib for the Treatment of Non-Small-Cell Lung Cancer
Expert Opinion on Pharmacotherapy
Medicine
Pharmacology